April 2014 FDA Recall Drug by Wockhardt Usa Inc.
D-0304-2015 - Failed Dissolution Specifications

This Class III drug recall was voluntarily initiated by Wockhardt Usa Inc. on April 17, 2014 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0304-2015

Reason for Recall
Failed Dissolution Specifications: Product was out of specification (OOS) at the 12 month long term stability testing point.
Initiated
04-17-2014
Reported
12-24-2014
Quantity
1,118,400 extended release tablets

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Wockhardt Metoprolol Succinate, Extended-Release Tablets USP, 50 mg, a)100-count HDPE bottle (NDC 64679-735-02), b) 4000-count pack (64679-735-08), Manufactured by: Wockhardt Limited, Mumbai, India Distributed by Wockhardt USA LLC. 20 Waterview Blvd. Parsippany, NJ 07054 USA .

Batch or Lot Expiration Information

Lot# a)
Lot# LN10392; Exp. 12/14 b)
Lot# LN10360; Exp. 12/14